A meta-analysis evaluating the objective response rates to PD-1/PD-L1 inhibitors in HCC patients from the TCGA cohort observed that there was no correlation with the presence of a viral HBV/HCV-induced cirrhosis. This evidence concerns the gene CD274 and hepatocellular carcinoma.